O. Heinzlef

1.3k total citations
18 papers, 531 citations indexed

About

O. Heinzlef is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, O. Heinzlef has authored 18 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 5 papers in Rheumatology. Recurrent topics in O. Heinzlef's work include Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (3 papers) and Systemic Lupus Erythematosus Research (3 papers). O. Heinzlef is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (3 papers) and Systemic Lupus Erythematosus Research (3 papers). O. Heinzlef collaborates with scholars based in France, Martinique and Italy. O. Heinzlef's co-authors include E Roullet, P. Cabré, J C Vernant, Didier Smadja, G Buisson, Odile Béra, R. Bellance, H. Merle, Christina Wolfson and Olivier Gout and has published in prestigious journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry and Journal of Medical Genetics.

In The Last Decade

O. Heinzlef

17 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Heinzlef France 10 311 235 139 64 56 18 531
Dorlan Kimbrough United States 12 344 1.1× 232 1.0× 115 0.8× 41 0.6× 15 0.3× 21 517
Edgar Carnero Contentti Argentina 17 732 2.4× 465 2.0× 214 1.5× 52 0.8× 29 0.5× 91 957
Salim Chahin United States 14 339 1.1× 158 0.7× 68 0.5× 42 0.7× 16 0.3× 28 460
Sara Salama Egypt 10 446 1.4× 473 2.0× 166 1.2× 102 1.6× 25 0.4× 22 637
Antonio Martı́nez-Yélamos Spain 12 279 0.9× 157 0.7× 79 0.6× 28 0.4× 21 0.4× 33 451
Daniela Alberti Italy 14 133 0.4× 276 1.2× 39 0.3× 42 0.7× 62 1.1× 21 431
Nuria García‐Barragán Spain 10 197 0.6× 264 1.1× 85 0.6× 28 0.4× 22 0.4× 20 392
José Manuel García‐Domínguez Spain 14 346 1.1× 132 0.6× 51 0.4× 20 0.3× 15 0.3× 52 609
Harold Moses United States 12 145 0.5× 176 0.7× 53 0.4× 67 1.0× 15 0.3× 19 492
Reza Vosoughi Canada 9 194 0.6× 107 0.5× 55 0.4× 29 0.5× 21 0.4× 22 354

Countries citing papers authored by O. Heinzlef

Since Specialization
Citations

This map shows the geographic impact of O. Heinzlef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Heinzlef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Heinzlef more than expected).

Fields of papers citing papers by O. Heinzlef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Heinzlef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Heinzlef. The network helps show where O. Heinzlef may publish in the future.

Co-authorship network of co-authors of O. Heinzlef

This figure shows the co-authorship network connecting the top 25 collaborators of O. Heinzlef. A scholar is included among the top collaborators of O. Heinzlef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Heinzlef. O. Heinzlef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bonnyaud, Céline, Sophie Hameau, Raphaël Zory, et al.. (2025). Intensive interdisciplinary specialized rehabilitation or regular physiotherapy for multiple sclerosis? A randomised controlled trial with economic evaluation. Annals of Physical and Rehabilitation Medicine. 68(2). 101898–101898.
2.
Louapre, Céline, Nicolas Collongues, Bruno Stankoff, et al.. (2020). Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. Multiple Sclerosis Journal. 26. 49–50. 84 indexed citations
3.
Gay, Marie‐Claire, et al.. (2019). Cross-cultural validation of a French version of the Emotional Processing Scale (EPS-25). European Review of Applied Psychology. 69(3). 91–99. 8 indexed citations
4.
Donzé, C., Aurélien Dinh, O. Heinzlef, & Patrick Hautecœur. (2015). Traiter ou ne pas traiter les bactériuries asymptomatiques avant bolus de méthylprednisolone ?. Revue Neurologique. 171(8-9). 669–673. 1 indexed citations
5.
Heinzlef, O., et al.. (2012). Traitement médicamenteux de la spasticité dans la sclérose en plaques. Revue Neurologique. 168. S62–S68. 3 indexed citations
6.
Debouverie, Marc, et al.. (2007). A longitudinal observational study of a cohort of patients with relapsing–remitting multiple sclerosis treated with glatiramer acetate. European Journal of Neurology. 14(11). 1266–1274. 13 indexed citations
7.
Régnier, Stéphane A., et al.. (2003). [Livedo-like dermatitis (Nicolau's syndrome) after injection of Copolymer-1 (Glatiramer acetate)].. PubMed. 159(5 Pt 1). 571–3. 19 indexed citations
8.
Heinzlef, O.. (2002). Anticardiolipin antibodies in patients with multiple sclerosis do not represent a subgroup of patients according to clinical, familial, and biological characteristics. Journal of Neurology Neurosurgery & Psychiatry. 72(5). 647–649. 36 indexed citations
9.
Cabré, P., O. Heinzlef, H. Merle, et al.. (2001). MS and neuromyelitis optica in Martinique (French West Indies). Neurology. 56(4). 507–514. 125 indexed citations
10.
Heinzlef, O., Alan R. Cohen, & Pierre Amarenco. (2001). [Atherosclerotic aortic plaques and risk of embolic stroke].. PubMed. 157(6-7). 619–31. 8 indexed citations
11.
Sazdovitch, V., M H Verdier-Taillefer, O. Heinzlef, Sonia Alamowitch, & E Roullet. (2000). [Familial multiple sclerosis: study of 357 consecutive patients].. PubMed. 156(6-7). 638–40. 7 indexed citations
12.
Heinzlef, O., Sonia Alamowitch, V. Sazdovitch, et al.. (2000). Autoimmune diseases in families of French patients with multiple sclerosis. Acta Neurologica Scandinavica. 101(1). 36–40. 55 indexed citations
13.
Marrie, Ruth Ann, Christina Wolfson, Miriam Sturkenboom, et al.. (2000). Multiple sclerosis and antecedent infections. Neurology. 54(12). 2307–2310. 67 indexed citations
14.
Heinzlef, O., Caroline Paternotte, Florence Mahieux, et al.. (1998). Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2p.. Journal of Medical Genetics. 35(2). 89–93. 50 indexed citations
15.
Amrani, Mehdi El, et al.. (1998). Brain infarction following 5-fluorouracil and cisplatin therapy. Neurology. 51(3). 899–901. 31 indexed citations
16.
Heinzlef, O., et al.. (1997). [Acute aseptic meningitis after hepatitis B vaccination].. PubMed. 26(7). 328–328. 5 indexed citations
17.
Olindo, S, David M. Smadja, P. Cabré, Hossein Mehdaoui, & O. Heinzlef. (1997). [Gayet-Wernicke encephalopathy and centropontine myelionolysis induced by hyperemesis gravidarum].. PubMed. 153(6-7). 427–9. 10 indexed citations
18.
Heinzlef, O., et al.. (1996). [Spontaneous regression of primary cerebral lymphoma].. PubMed. 152(2). 135–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026